Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jaya Nayini"'
Autor:
Azra Raza, Wei-Tong Hsu, Naomi Galili, Parameswaran Venugopal, Ian Janssen, Jie Yang, Harvey D. Preisler, Jaya Nayini, Betty Gladstone, S. Sivaraman
Publikováno v:
Leukemia Research. 27:529-537
A novel method for simultaneously detecting clonality by FISH, and presence of telomerase activity (telo+ cells) or histone H3 mRNA (H3+) in single cells from a mixed leukemic population is reported. The methods were validated using K562 cells mixed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::571f631ef66554244edf2517b872e748
https://doi.org/10.1016/s0145-2126(02)00267-9
https://doi.org/10.1016/s0145-2126(02)00267-9
Autor:
Shiwen Song, Min Tao, Marc Toofanfard, Biaoru Li, Harvey D. Preisler, Alan Larson, S. Sivaraman, Jaya Nayini, Hong Chen, Parameswaran Venugopal
Publikováno v:
Leukemia & Lymphoma. 41:161-168
Both IL-4 and IL-10 have been shown in vitro to inhibit leukemia cell secretion of IL-1beta, GM-CSF, and TNFalpha, and increase leukemia cell release of IL-1ra. In this study, we have investigated the in vivo effects of IL-4, IL-10, and amifostine on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a819cc28a2f3f64c38c8e0926298176a
https://doi.org/10.3109/10428190109057966
https://doi.org/10.3109/10428190109057966
Autor:
Biaoru Li, Parameswaran Venugopal, Jie Yang, E. Devemy, S. Creech, Jaya Nayini, L. Fisher, Wei-Tong Hsu, Harvey D. Preisler, M. Tao, Harpreet Chopra, C. Kaspar, Erzsebet Horvath
Publikováno v:
Leukemia research. 25(9)
This is the third paper in a series which describes a new remission induction regimen for patients with 'poor prognosis' acute myelogenous leukemia (AML). Twenty-four patients were treated with two one day pulses of chemotherapy separated by 96 h. Ea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6d06e4e1c8e4963a9c9b34d63bca536
https://pubmed.ncbi.nlm.nih.gov/11489472
https://pubmed.ncbi.nlm.nih.gov/11489472
Autor:
Ming Tao, Jie Yang, Paramesaran Venugopal, Erzsebet Horvath, Harvey D. Preisler, Harpareet Chopra, Jaya Nayini, Biarou Li, PeterM Meyer
Publikováno v:
Leukemia research. 24(9)
Biological and molecular biological studies were performed on the marrow cells of 25 patients with poor prognosis AML to both characterize this type of leukemia and to assess the relationship between the parameters which were measured and treatment o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfca576ef10bb374c938b08f9d6b8d95
https://pubmed.ncbi.nlm.nih.gov/10978783
https://pubmed.ncbi.nlm.nih.gov/10978783
Autor:
Shiwen Song, Ray Win Huang, Min Tao, Parameswaran Venugopal, Colleen B. Andrews, Emmanuelle Devemy, Harvey D. Preisler, Biaoru Li, Jaya Nayini
Publikováno v:
Cytokine. 12(6)
This study compared cytokine transcript and protein levels in BM cells of normal individuals and leukemic patients. AML differed from normal in that: (1) AML marrow cells contain more IL-1beta protein than normal cells, (2) IL-1ra transcripts are abs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a986720e8ff3900b6f0750363c47099
https://pubmed.ncbi.nlm.nih.gov/10843748
https://pubmed.ncbi.nlm.nih.gov/10843748
Autor:
S. Sivaraman, Parameswaran Venugopal, Xiao-Ke Huang, Stephanie A. Gregory, Jaya Nayini, Harvey D. Preisler
Publikováno v:
Leukemia research. 24(5)
Anti-CD20 antibody is an established treatment for low-grade non-Hodgkin’s lymphoma (NHL). Augmenting the expression of CD20 antigen on the tumor cells may increase the cell kill and therefore increase the effectiveness of the antibody. To study th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65c95fc033cfaf91421f6956eb9502a9
https://pubmed.ncbi.nlm.nih.gov/11203684
https://pubmed.ncbi.nlm.nih.gov/11203684
Autor:
Colleen B. Andrews, Biaoru Li, Parameswaran Venugopal, Harvey D. Preisler, Jaya Nayini, Min Tao, Jie Yang
Publikováno v:
Blood. 94:373-374
To the Editor: After the Shc gene was identified, biological function studies have focused on the oncogenic potentials of Shc proteins, especially their role in the Ras-dependent mitogen-activated protein kinase activation.[1][1] [2][2] Jucker et al[
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cebaa4a1922728bbc96f8b50cee6f030
https://doi.org/10.1182/blood.v94.1.373.413a48b_373_374
https://doi.org/10.1182/blood.v94.1.373.413a48b_373_374
Autor:
Parameswaran Venugopal, Azra Raza, S. Sivaraman, J. Yang, H. Chopra, Biaoru Li, Stephanie A. Gregory, Jaya Nayini, Solomon S. Adler, L. Fisher, Harvey D. Preisler, H. Chen, E. Devemy, M. Tao
Publikováno v:
Experimental Hematology. 28:107
Studies were conducted of p15 methylation and expression and of cytokine levels in bone marrow cells during the development of AML. Surprisingly, the p15 gene was frequently methylated in the marrows of patients who had been cured of lymphoma and in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08c89ff9369a89425b18982f77c89f74
https://doi.org/10.1016/s0301-472x(00)00419-7
https://doi.org/10.1016/s0301-472x(00)00419-7